Active Ingredient(s): Berotralstat Hydrochloride
FDA Approved: * December 3, 2020
Pharm Company: * BIOCRYST
Category: Genetic Disorders

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Orladeyo Overview

Berotralstat, sold under the brand name Orladeyo, is a medication used to prevent attacks of hereditary angioedema (HAE) in people twelve years and older.[3][4][2] The most common side effects include abdominal pain, vomiting, diarrhea, back pain, and heartburn.[2] Berotralstat was approved for medical use in the United States in December 2020.[2][5] History Berotralstat was approved based on ev...

Read more Orladeyo Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Berotralstat

Recent Orladeyo Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Berotralstat Hydrochloride
  • Capsule: 110mg, 150mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Berotralstat Hydrochloride or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 4 August 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA